Klin Onkol 2015; 28(Suppl 3): 95-104. DOI: 10.14735/amko20153S95.
Summary
Despite achieving promising treatment results in patients with lymphoma, there is still a signifi cant proportion of patients who relapse or have refractory disease. Salvage therapy followed by high dose treatment with autologous stem-cell transplantation is the standard of care in many of them. The role allogeneic stem-cell transplantation, especially after reduced intensity conditioning, is under extensive investigation. This review article presents current knowledge and recommendation in the salvage treatment of relapsed/ refractory lymphomas.
